[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Gsk Plc ADR (GSK)

Gsk Plc ADR (GSK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.

Haleon plc (HLN) is one of the world's largest consumer healthcare companies, formed from the combined consumer health divisions of GSK (GSK), Pfizer (PFE), and Novartis (NVS), and went public in July 2022. Haleon operates across six major therapeutic categories: oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health, and therapeutic skin health.

Its iconic brand portfolio includes Sensodyne, Advil, Centrum, Panadol, Voltaren, and Theraflu, spanning markets across North America, EMEA, Latin America, and Asia Pacific, making it a go-to name in the everyday wellness and self-care space.

Fundamentals

See More
  • Market Capitalization, $K 108,668,368
  • Shares Outstanding, K 2,025,128
  • Annual Sales, $ 43,078 M
  • Annual Income, $ 7,538 M
  • EBIT $ 10,759 M
  • EBITDA $ 13,810 M
  • 60-Month Beta 0.35
  • Price/Sales 2.41
  • Price/Cash Flow 8.54
  • Price/Book 4.43

Options Overview Details

View History
  • Implied Volatility 29.10% (+0.48%)
  • Historical Volatility 27.18%
  • IV Percentile 63%
  • IV Rank 28.18%
  • IV High 61.51% on 10/23/25
  • IV Low 16.39% on 12/08/25
  • Expected Move (DTE 6) 1.18 (2.20%)
  • Put/Call Vol Ratio 0.43
  • Today's Volume 2,860
  • Volume Avg (30-Day) 5,427
  • Put/Call OI Ratio 1.29
  • Today's Open Interest 73,031
  • Open Int (30-Day) 61,993
  • Expected Range 52.48 to 54.84

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.27
  • Number of Estimates 5
  • High Estimate $1.30
  • Low Estimate $1.25
  • Prior Year $1.23
  • Growth Rate Est. (year over year) +3.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
49.39 +8.65%
on 06/03/26
53.83 -0.33%
on 07/02/26
+4.66 (+9.51%)
since 06/02/26
3-Month
48.57 +10.48%
on 06/02/26
59.57 -9.92%
on 04/14/26
-3.03 (-5.34%)
since 04/02/26
52-Week
35.45 +51.37%
on 07/17/25
61.69 -13.02%
on 02/18/26
+15.15 (+39.34%)
since 07/02/25

Most Recent Stories

More News
Trump’s Newly Disclosed Moderna Trades Preceded FDA Advisory Panel’s Unanimous Backing of mRNA Flu Vaccine

President Donald Trump’s stock transaction filings reveal multiple purchases of Moderna ($MRNA) during March 2026, followed by a partial sale on May 18. Since those trades, the FDA's Vaccines and Related...

MRNA : 79.76 (+10.01%)
PFE : 24.32 (+1.84%)
GSK : 53.66 (+4.60%)
Haleon Just Struck a Five-Year Deal With Microsoft. Here Is What It Means for Haleon Stock.

Haleon has struck a five-year partnership with Microsoft as it looks to expand its AI transformation using Microsoft's Copilot.

TGT : 130.21 (-0.06%)
MSFT : 390.49 (+1.62%)
$SRCS : 942.10 (+2.41%)
COST : 951.67 (+2.92%)
NVS : 159.90 (+3.74%)
HLN : 9.82 (+4.47%)
GSK : 53.66 (+4.60%)
PFE : 24.32 (+1.84%)
WMT : 111.84 (+2.78%)
Tempus AI Stock Faces a Make-or-Break Moment After Its Recent Pullback

Tempus AI's stock has hit a rough patch, but fundamentals remain solid. What does it mean for investors?

ARKG : 42.91 (+0.68%)
AZN : 195.15 (+6.14%)
MRK : 129.56 (+3.34%)
GILD : 131.27 (+4.21%)
TEM : 60.27 (-2.16%)
GSK : 53.66 (+4.60%)
ARKK : 81.25 (-0.73%)
BMY : 58.13 (+4.16%)
MarketBeat Week in Review – 06/08 - 06/12

Stocks rallied on optimism surrounding a potential U.S.-Iran peace deal and SpaceX's historic IPO debut, reinforcing investor confidence and market momentum

NVDA : 194.83 (-1.39%)
GOOGL : 359.91 (-0.36%)
AAPL : 308.63 (+4.84%)
WING : 177.99 (+1.73%)
SPOT : 485.97 (+2.86%)
CBRL : 53.50 (-2.90%)
P : 72.71 (-5.74%)
IREN : 38.82 (-10.39%)
TSLA : 393.45 (-7.49%)
SPCX : 162.00 (+2.83%)
INTC : 120.35 (-5.25%)
NUVL : 123.73 (+0.11%)
Patent Cliff Predators: GSK Acquires Nuvalent For $10.6 Billion

GSK agreed to acquire Nuvalent for $10.6 billion, or $124 per share, a roughly 40% premium, to add two late-stage lung cancer assets and offset an impending patent cliff.

RHHVF : 410.8000 (-1.39%)
NUVL : 123.73 (+0.11%)
GSK : 53.66 (+4.60%)
PFE : 24.32 (+1.84%)
Nuvalent Stock Hits All-Time High Following GSK's Buyout Offer

Nuvalent shares soar as GSK announces a $10.6 billion buyout deal. But is it too late already to invest in NUVL stock?

NUVL : 123.73 (+0.11%)
RHHBY : 53.0400 (+5.41%)
GSK : 53.66 (+4.60%)
PFE : 24.32 (+1.84%)
Buying CBRS Stock After the Cerebras IPO Is a Bet on Engineering Magic. That Same Magic Could Be the Kiss of Death.

The Cerebras IPO is the most significant debut in the semiconductor industry since Arm.

NVDA : 194.83 (-1.39%)
AZN : 195.15 (+6.14%)
AMD : 517.82 (-4.26%)
ARM : 315.28 (-6.58%)
GSK : 53.66 (+4.60%)
TSM : 434.16 (-2.27%)
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat

Big Pharma stalwarts AbbVie, AstraZeneca, and GSK beat Q1 revenue expectations, raising guidance and offering a potential tailwind for the flailing medical sector.

AZN : 195.15 (+6.14%)
ABBV : 261.07 (+3.99%)
GSK : 53.66 (+4.60%)
GSK's Vaccine Momentum Meets the HIV Patent Cliff This Week—Can Specialty Medicine Bridge the Gap?

Barchart Research What to Expect from GSK Earnings GSK Generated April 28, 2026 Current Price $54.47 EPS Estimate $$1.17 Consensus Rating Hold Average Move 4.32% GSK's Vaccine Momentum Meets the HIV Patent...

GSK : 53.66 (+4.60%)
3 Bargain-Cheap Small Caps Worth a Second Look

Three low P/E small-cap stocks offer distinct catalysts and upside potential as investors look ahead to a broader market rally

WEN : 8.60 (-3.80%)
INVA : 22.31 (+1.87%)
GSK : 53.66 (+4.60%)
NBR : 77.86 (+0.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.

See More

Key Turning Points

3rd Resistance Point 55.83
2nd Resistance Point 54.83
1st Resistance Point 54.25
Last Price 53.66
1st Support Level 52.66
2nd Support Level 51.66
3rd Support Level 51.08

See More

52-Week High 61.69
Last Price 53.66
Fibonacci 61.8% 51.67
Fibonacci 50% 48.57
Fibonacci 38.2% 45.48
52-Week Low 35.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.